About the Program
Join us for our May ALS Learning Series with Dr. Kelly Gwathmey from Virginia Commonwealth University. She will explore the causes and consequences of ALS diagnostic delay, along with potential solutions to address this problem. A Q&A will follow.
The Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to the Gilbert & Jacqueline Fern Foundation & Mitsubishi Tanabe Pharma America for sponsoring this webinar.
About the Speaker
Kelly Gwathmey is an Associate Professor of Neurology at Virginia Commonwealth University in Richmond, Virginia. She studied Neuroscience and Behavioral Biology at Emory University in Atlanta, Georgia. She then attended Eastern Virginia Medical School in Norfolk, Virginia. Her Neurology and Clinical Neurophysiology training was completed at the University of Virginia. Following this, she completed a Neuromuscular Medicine fellowship at both Brigham and Women’s Hospital and Massachusetts General Hospital in Boston. At the University of Virginia, she started the multidisciplinary MDA clinic, was co-director of the ALS clinic, and was the fellowship director for both the Neuromuscular and Clinical Neurophysiology fellowships. She joined VCU in January 2019 and currently serves in the capacity of Neuromuscular Division Chair, Neuromuscular Medicine Program Director and EMG Laboratory Director. Dr. Gwathmey sees a wide spectrum of neuromuscular patients and performs electrodiagnostic studies (nerve conduction studies and electromyography). Her research interests include environmental risk factors in ALS, diagnostic delay in ALS, and racial disparities in healthcare.